特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
308870

世界のゲノミクス市場:2020年~2024年

Global Genomics Market 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 100 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
世界のゲノミクス市場:2020年~2024年
出版日: 2020年01月14日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 100 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のゲノミクス市場は、2020年から2024年にかけて13%のCAGRで1723億米ドル規模の市場に成長すると予測されています。当市場は、ゲノムデータベースの作成および更新に対する需要の高まりによって成長が促進されています。また、単一細胞ベースのゲノム解析の採用拡大により、当市場の成長が促される見通しです。

当レポートでは、世界のゲノミクス市場を調査し、市場の概要、ソリューション・地域別の市場規模の推移と予測、市場動向、成長要因および課題の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポート範囲

  • 序文
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場エコシステム
  • 市場の特徴
  • 市場セグメンテーション分析
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 2019年の市場規模
  • 市場規模と予測
  • 市場の見通し

第5章 ファイブフォース分析

  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
  • 市場状況

第6章 市場セグメンテーション:ソリューション別

  • 市場区分:ソリューション別
  • 市場比較:ソリューション別
  • 製品
  • サービス
  • 市場機会:ソリューション別

第7章 顧客情勢

第8章 市場セグメンテーション:地域別

  • 市場区分:地域別
  • 市場比較:地域別
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • 単一細胞ベースのゲノム解析の採用増加
  • シーケンス技術の進歩
  • 精密医療と遺伝子治療の成長の進展

第12章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競争シナリオ

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Agilent Technologies Inc.
  • BGI Genomics Co. Ltd.
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • General Electric Co.
  • Illumina Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 Technavioについて

目次
Product Code: IRTNTR40876

Technavio has been monitoring the global genomics market and it is poised to grow by USD 17.23 bn during 2020-2024, progressing at a CAGR of 13% during the forecast period. Our reports on genomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing demand for creating and upgrading genome databases. In addition, growing adoption of single cell-based genomic analysis is anticipated to boost the growth of the genomics market as well.

Market Segmentation

Technavio's genomics market is segmented as below:

Solution

  • Products
  • Services

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for genomics market growth

This study identifies growing adoption of single cell-based genomic analysis as the prime reasons driving the genomics market growth during the next few years.

Prominent vendors in genomics market

We provide a detailed analysis of around 25 vendors operating in the genomics market, including some of the vendors such as Agilent Technologies Inc., BGI Genomics Co. Ltd. , Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., General Electric Co., Illumina Inc., PerkinElmer Inc., QIAGEN NV and Thermo Fisher Scientific Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY SOLUTION

  • Market segmentation by solution
  • Comparison by solution
  • Products - Market size and forecast 2019-2024
  • Services - Market size and forecast 2019-2024
  • Market opportunity by solution

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing adoption of single cell-based genomic analysis
  • Advances in sequencing technologies
  • Growing developments in precision medicine and gene therapy

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • BGI Genomics Co. Ltd.
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • General Electric Co.
  • Illumina Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

  • Exhibit 01: Global life sciences tools and services market
  • Exhibit 02: Segments of global life sciences tools and services market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendors: Key offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Solution - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by solution
  • Exhibit 20: Products - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Products - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Services - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Services - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by solution
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Vendor landscape
  • Exhibit 40: Landscape disruption
  • Exhibit 41: Vendors covered
  • Exhibit 42: Vendor classification
  • Exhibit 43: Market positioning of vendors
  • Exhibit 44: Agilent Technologies Inc. - Vendor overview
  • Exhibit 45: Agilent Technologies Inc. - Business segments
  • Exhibit 46: Agilent Technologies Inc. - Organizational developments
  • Exhibit 47: Agilent Technologies Inc. - Geographic focus
  • Exhibit 48: Agilent Technologies Inc. - Segment focus
  • Exhibit 49: Agilent Technologies Inc. - Key offerings
  • Exhibit 50: BGI Genomics Co. Ltd. - Vendor overview
  • Exhibit 51: BGI Genomics Co. Ltd. - Business segments
  • Exhibit 52: BGI Genomics Co. Ltd. - Organizational developments
  • Exhibit 53: BGI Genomics Co. Ltd. - Key offerings
  • Exhibit 54: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 55: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 56: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 57: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 58: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 59: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 60: Danaher Corp. - Vendor overview
  • Exhibit 61: Danaher Corp. - Business segments
  • Exhibit 62: Danaher Corp. - Organizational developments
  • Exhibit 63: Danaher Corp. - Geographic focus
  • Exhibit 64: Danaher Corp. - Segment focus
  • Exhibit 65: Danaher Corp. - Key offerings
  • Exhibit 66: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 67: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 68: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 69: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 70: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 71: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 72: General Electric Co. - Vendor overview
  • Exhibit 73: General Electric Co. - Business segments
  • Exhibit 74: General Electric Co. - Organizational developments
  • Exhibit 75: General Electric Co. - Geographic focus
  • Exhibit 76: General Electric Co. - Segment focus
  • Exhibit 77: General Electric Co. - Key offerings
  • Exhibit 78: Illumina Inc. - Vendor overview
  • Exhibit 79: Illumina Inc. - Business segments
  • Exhibit 80: Illumina Inc. - Organizational developments
  • Exhibit 81: Illumina Inc. - Geographic focus
  • Exhibit 82: Illumina Inc. - Segment focus
  • Exhibit 83: Illumina Inc. - Key offerings
  • Exhibit 84: PerkinElmer Inc. - Vendor overview
  • Exhibit 85: PerkinElmer Inc. - Business segments
  • Exhibit 86: PerkinElmer Inc. - Organizational developments
  • Exhibit 87: PerkinElmer Inc. - Geographic focus
  • Exhibit 88: PerkinElmer Inc. - Segment focus
  • Exhibit 89: PerkinElmer Inc. - Key offerings
  • Exhibit 90: QIAGEN NV - Vendor overview
  • Exhibit 91: QIAGEN NV - Business segments
  • Exhibit 92: QIAGEN NV - Organizational developments
  • Exhibit 93: QIAGEN NV - Geographic focus
  • Exhibit 94: QIAGEN NV - Segment focus
  • Exhibit 95: QIAGEN NV - Key offerings
  • Exhibit 96: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 97: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 98: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 99: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 100: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 101: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 102: Validation techniques employed for market sizing
  • Exhibit 103: Definition of market positioning of vendors
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.